Integrating Touchscreen-Based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma to Drive Personalized Treatment Decisions
Kurtin, Sandra E
Mohile, Supriya Gupta
Catamero, Donna D
Tompkins Stricker, Carrie
Wildes, Tanya Marya
AffiliationUniv Arizona, Ctr Canc
MetadataShow full item record
PublisherAMER SOC CLINICAL ONCOLOGY
CitationNathwani, N., Kurtin, S. E., Lipe, B., Mohile, S. G., Catamero, D. D., Wujcik, D., ... & Wildes, T. M. (2020). Integrating touchscreen-based geriatric assessment and frailty screening for adults with multiple myeloma to drive personalized treatment decisions. JCO oncology practice, 16(1), e92-e99.
JournalJCO ONCOLOGY PRACTICE
Rights© 2019 by American Society of Clinical Oncology.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractPatients were white (72%; n = 86), mean age was 72 years (range, 65-85 years), and averaged 7.71 minutes (range, 2-17 minutes) for survey completion. Providers averaged 3.2 minutes (range, 1-10 minutes) to review mGA results. Using International Myeloma Working Group frailty score, patients were fit (39%; n = 64), intermediate fit (33%; n = 55), or frail (28%; n = 46). Providers selected more aggressive treatments in 16.3% of patients and decreased treatment intensity in 34% of patients; treatment intensification was more common for fit patients and milder treatments for frail patients (χ2 = 20.02; P < .0001). Transplant eligibility significantly correlated with fit status and transplant ineligibility with frail status (P = .004). Outcomes on 144 patients 3 months post study visit showed 19.4% (n = 28) had grade ≥ 3 hematologic toxicities, 38.9% (n = 56) had dose modifications, and 18% (n = 26) had early therapy cessation.
Note12 month embargo; first published online 25 November 2019
VersionFinal published version
- Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
- Authors: Engelhardt M, Dold SM, Ihorst G, Zober A, Möller M, Reinhardt H, Hieke S, Schumacher M, Wäsch R
- Issue date: 2016 Sep
- Elderly patients with multiple myeloma: towards a frailty approach?
- Authors: Zweegman S, Engelhardt M, Larocca A, EHA SWG on ‘Aging and Hematology’
- Issue date: 2017 Sep
- Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.
- Authors: Efficace F, Gaidano G, Petrucci MT, Niscola P, Cottone F, Codeluppi K, Antonioli E, Tafuri A, Larocca A, Potenza L, Fozza C, Pastore D, Rigolin GM, Offidani M, Romano A, Kyriakou C, Cascavilla N, Gozzetti A, Derudas D, Vignetti M, Cavo M
- Issue date: 2022 Sep
- Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population.
- Authors: Lee HS, Lee J, Jo JC, Jung SH, Lee JJ, Kim D, Lee S, Song K
- Issue date: 2021 Nov 25
- Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis.
- Authors: Salazar AS, Recinos LM, Mian HS, Stoll C, Simon LE, Sekhon S, Colditz GA, Wildes TM
- Issue date: 2019 Aug